# High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)

> **NCT06489704** · NA · COMPLETED · sponsor: **University of Zurich** · enrollment: 24 (actual)

## Conditions studied

- High Altitude Pulmonary Hypertension

## Interventions

- **OTHER:** Echocardiography

## Key facts

- **NCT ID:** NCT06489704
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-02
- **Primary completion:** 2024-09-27
- **Final completion:** 2024-09-27
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06489704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06489704, "High Altitude (HA) Residents With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Artery Pressure (PAP) Assessed at HA (3200 m) vs LA (760 m)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06489704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*